Literature DB >> 15855169

Reactive carbonyls and polyunsaturated fatty acids produce a hydroxyl radical-like species: a potential pathway for oxidative damage of retinal proteins in diabetes.

Subramaniam Pennathur1, Yasuo Ido, Jozsef I Heller, Jaeman Byun, Ratna Danda, Pablo Pergola, Joseph R Williamson, Jay W Heinecke.   

Abstract

The pattern of oxidized amino acids in aortic proteins of nonhuman primates suggests that a species resembling hydroxyl radical damages proteins when blood glucose levels are high. However, recent studies argue strongly against a generalized increase in diabetic oxidative stress, which might instead be confined to the vascular wall. Here, we describe a pathway for glucose-stimulated protein oxidation and provide evidence of its complicity in diabetic microvascular disease. Low density lipoprotein incubated with pathophysiological concentrations of glucose became selectively enriched in ortho-tyrosine and meta-tyrosine, implicating a hydroxyl radical-like species in protein damage. Model system studies demonstrated that the reaction pathway requires both a reactive carbonyl group and a polyunsaturated fatty acid, involves lipid peroxidation, and is blocked by the carbonyl scavenger aminoguanidine. To explore the physiological relevance of the pathway, we used mass spectrometry and high pressure liquid chromatography to quantify oxidation products in control and hyperglycemic rats. Hyperglycemia raised levels of ortho-tyrosine, meta-tyrosine, and oxygenated lipids in the retina, a tissue rich in polyunsaturated fatty acids. Rats that received aminoguanidine did not show this increase in protein and lipid oxidation. In contrast, rats with diet-induced hyperlipidemia in the absence of hyperglycemia failed to exhibit increased protein and lipid oxidation products in the retina. Our observations suggest that generation of a hydroxyl radical-like species by a carbonyl/polyunsaturated fatty acid pathway might promote localized oxidative stress in tissues vulnerable to diabetic damage. This raises the possibility that antioxidant therapies that specifically inhibit the pathway might delay the vascular complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855169     DOI: 10.1074/jbc.M500839200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD.

Authors:  Daryl M Okamura; Subramaniam Pennathur; Katie Pasichnyk; Jesús M López-Guisa; Sarah Collins; Maria Febbraio; Jay Heinecke; Allison A Eddy
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

2.  Misincorporation of free m-tyrosine into cellular proteins: a potential cytotoxic mechanism for oxidized amino acids.

Authors:  Hande Gurer-Orhan; Nuran Ercal; Suneetha Mare; Subramaniam Pennathur; Hilmi Orhan; Jay W Heinecke
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

3.  Phosphatidylinositol 3 kinase pathway and 4-hydroxy-2-nonenal-induced oxidative injury in the RPE.

Authors:  Jianbin Chen; Ling Wang; Yan Chen; Paul Sternberg; Jiyang Cai
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-20       Impact factor: 4.799

4.  Quantitative analysis of amino Acid oxidation markers by tandem mass spectrometry.

Authors:  Anuradha Vivekanandan-Giri; Jaeman Byun; Subramaniam Pennathur
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

5.  Influence of polymorphisms in VEGF, ACE, TNF and GST genes on the susceptibility to retinopathy of prematurity among Chinese infants.

Authors:  Xiao-Jun Lei; Yong-Xia Zhao; Tong Qiao
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

6.  Traditional reactive carbonyl scavengers do not prevent the carbonylation of brain proteins induced by acute glutathione depletion.

Authors:  J Zheng; O A Bizzozero
Journal:  Free Radic Res       Date:  2010-03

7.  Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

Authors:  Hongyu Zhang; Jharna Saha; Jaeman Byun; MaryLee Schin; Matthew Lorenz; Robert T Kennedy; Matthias Kretzler; Eva L Feldman; Subramaniam Pennathur; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

8.  Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.

Authors:  Andrea M Vincent; John M Hayes; Lisa L McLean; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Eva L Feldman
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

9.  Decreased nitric oxide bioavailability in a mouse model of Fabry disease.

Authors:  Liming Shu; James L Park; Jaeman Byun; Subramaniam Pennathur; Jessica Kollmeyer; James A Shayman
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

10.  Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.

Authors:  Timothy D Wiggin; Matthias Kretzler; Subramaniam Pennathur; Kelli A Sullivan; Frank C Brosius; Eva L Feldman
Journal:  Endocrinology       Date:  2008-06-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.